Provisions on Vaccination in COVID-19, Xi 'an

Legal analysis: 1. Vaccine types

The varieties of COVID-19 vaccine for people aged 12-17 are "Inactivated Covid-19 Vaccine from Sinopharm Zhongsheng Beijing Institute" and "Inactivated Kexing Zhongxin Crown Virus Vaccine".

China has completed the third phase clinical trial of inactivating COVID-19 vaccine, which shows that the vaccine is safe, reliable and effective. After vaccination, there is no difference in antibody level and protective efficacy between adults over 18 years old.

II. Vaccination principle

All the vaccinations are free of charge and are carried out in an orderly manner according to the principle of "all kinds should be planted, informed and voluntary, safe and orderly".

III. Vaccination arrangement

According to the national and Covid-19 vaccination implementation plan in the second half of Shaanxi Province, Covid-19 vaccination for people aged 12-17 was started in two stages, and the completion time was September 3th. The vaccination schedule is as follows:

1. People aged 15-17. Starting from July 23rd, people aged 15-17 will be vaccinated, and the whole course will be vaccinated twice before the end of August.

in February and August, vaccination was started for people aged 12-14. Complete two doses of vaccination before the end of September.

IV. Vaccination place

Vaccinate the Covid-19 vaccine of the population aged 12-17 at the nearest place of residence at the designated inoculation unit or temporary inoculation point. (Note: Please wait for the specific notice from the local education department or school. )

V. Vaccination suggestions

At present, many places have adopted the form of "big hands holding small hands" for COVID-19 vaccination. At the same time, parents who have not yet been vaccinated are also called upon to take the lead in responding to the call, register for vaccination actively and set an example for their children.

VI. Precautions

1. The Technical Guide for Vaccination in COVID-19 (First Edition) stipulates five common cases of vaccination contraindications, including: First, allergic to Covid-19 vaccine or similar vaccines before. Second, there has been a serious allergic reaction in the past vaccination. The third is suffering from uncontrolled serious nervous system diseases. Fourth, patients who are suffering from fever or acute attack of acute or chronic diseases. Fifth, uncontrolled patients with severe chronic diseases. Whether it can be vaccinated or not is judged by the pre-inspection doctor on the spot.

2. The inoculation process needs to be accompanied by the guardian all the time, and signed on the spot for confirmation. Parents and friends are requested to make arrangements in advance.

3. Before vaccination, the child's physical health should be evaluated, and the premise of actively responding to the call is to ensure that the child's physical condition meets the vaccination requirements.

4. The ID cards of guardians and children are required for vaccination registration. Parents and friends are requested to prepare in advance.

At the same time, in order to ensure the life, health and safety of the general public, please ask residents who meet the vaccination conditions to go to the vaccination site with valid identification according to the time requirements, and parents and friends should set a good example for their children.

Legal basis: Technical Guidelines for Vaccination in COVID-19 (First Edition)

(1) Applicable objects.

people aged p>18 and above.

(2) Inoculation times and intervals.

1. Covid-19 inactivated vaccine (Vero cells)

2 doses; The inoculation interval between the two doses is suggested to be 3 weeks, and the second dose should be completed as soon as possible within 8 weeks.

2. 1 dose of recombinant Covid-19 vaccine (adenovirus type 5 vector)

.

3. Three doses of recombinant Covid-19 vaccine (CHO cells)

; The inoculation interval between two adjacent doses is recommended to be 4 weeks. The second dose should be completed within 8 weeks after the first dose, and the third dose should be completed within 6 months after the first dose.

(III) Inoculation route and inoculation site

Intramuscular injection of upper arm deltoid muscle is recommended.